Clusterin as a therapeutic target for radiation sensitization in a lung cancer model

International Journal of Radiation Oncology Biology Physics

Volumn 63, Issue 4, 2005, Pages 1228-1236

  Cao, Carolyn ^a   Shinohara, Eric T ^a   Li, Hecheng ^a   Niermann, Ken J ^a   Kwang, Woon Kim ^a   Sekhar, Konjeti R ^a   Gleave, Martin ^b,c   Freeman, Michael ^a   Lu, Bo ^a,d  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

Angiogenesis inhibitors; Cancer; Clusterin; Radiation; Radiation sensitizing agents

Indexed keywords

BLOOD; CELLS; CHEMOTHERAPY; HEMODYNAMICS; MEDICAL PROBLEMS; RADIATION; TARGETS; TUMORS;

ANGIOGENESIS INHIBITORS; CLUSTERIN; RADIATION SENSITIZING AGENTS; THERAPEUTIC EFFICACY;

RADIOTHERAPY;

ANTISENSE OLIGODEOXYNUCLEOTIDE; CLUSTERIN; OGX 011; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER GRAFT; CANCER MODEL; CANCER RADIOTHERAPY; CELL DEATH; CELL SURVIVAL; CLONOGENIC ASSAY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; RADIOSENSITIZATION; STAINING; TREATMENT OUTCOME; TUMOR BLOOD FLOW; TUMOR GROWTH; XENOGRAFT;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CLUSTERIN; FEMALE; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM PROTEINS; OLIGONUCLEOTIDES, ANTISENSE; THIONUCLEOTIDES; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 27144556401     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.07.956     Document Type: Article

References (50)

1. M.E. Rosenberg, J. Silkensen Clusterin Physiologic and pathophysiologic considerations Int J Biochem Cell Biol 27 1995 633 645
2. J. Lakins, S.A. Bennett, J.H. Chen Clusterin biogenesis is altered during apoptosis in the regressing rat ventral prostate J Biol Chem 273 1998 27887 27895
3. K.B. Reddy, G. Jin, M.C. Karode Transforming growth factor beta (TGF beta)-induced nuclear localization of apolipoprotein J/clusterin in epithelial cells Biochemistry 35 1996 6157 6163
4. C.R. Yang, K. Leskov, K. Hosley-Eberlein Nuclear clusterin/XIP8, an X-ray-induced Ku70-binding protein that signals cell death Proc Natl Acad Sci USA 97 2000 5907 5912
5. A.E. Caccamo, M. Scaltriti, A. Caporali Cell detachment and apoptosis induction of immortalized human prostate epithelial cells are associated with early accumulation of a 45 kDa nuclear isoform of clusterin Biochem J 382 2004 157 168
6. S.E. Jones, C. Jomary Clusterin Int J Biochem Cell Biol 34 2002 427 431
7. H. Miyake, I. Hara, S. Kamidono Synergistic chemsensitization and inhibition of tumor growth and metastasis by the antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model Clin Cancer Res 7 2001 4245 4252
8. M.E. Gleave, H. Miyake, T. Zellweger Use of antisense oligonucleotides targeting the antiapoptotic gene, clusterin/testosterone-repressed prostate message 2, to enhance androgen sensitivity and chemosensitivity in prostate cancer Urology 58 2001 39 49
9. J. O'Sullivan, L. Whyte, J. Drake Alterations in the post-translational modification and intracellular trafficking of clusterin in MCF-7 cells during apoptosis Cell Death Differ 10 2003 914 927
10. T. Criswell, D. Klokov, M. Beman Repression of IR-inducible clusterin expression by the p53 tumor suppressor protein Cancer Biol Ther 2 2003 372 380
11. L. Debure, J.L. Vayssiere, V. Rincheval Intracellular clusterin causes juxtanuclear aggregate formation and mitochondrial alteration J Cell Sci 116 2003 3109 3121
12. M. Scaltriti, A. Santamaria, R. Paciucci Intracellular clusterin induces G2-M phase arrest and cell death in PC-3 prostate cancer cells Cancer Res 64 2004 6174 6182
13. J. Connor, R. Buttyan, C.A. Olsson SGP-2 expression as a genetic marker of progressive cellular pathology in experimental hydronephrosis Kidney Int 39 1991 1098 1103
14. N. Kyprianou, H.F. English, N.E. Davidson Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation Cancer Res 51 1991 162 166
15. L.E. French, A.P. Sappino, J. Tschopp Distinct sites of production and deposition of the putative cell death marker clusterin in the human thymus J Clin Invest 90 1992 1919 1925
16. J.A. Sensibar, D.M. Sutkowski, A. Raffo Prevention of cell death induced by tumor necrosis factor alpha in LNCaP cells by overexpression of sulfated glycoprotein-2 (clusterin) Cancer Res 55 1995 2431 2437
17. H. Miyake, C. Nelson, P.S. Rennie Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer Cancer Res 60 2000 170 176
18. H. Miyake, C. Nelson, P.S. Rennie Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models Cancer Res 60 2000 2547 2554
19. H. Miyake, K.N. Chi, M.E. Gleave Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo Clin Cancer Res 6 2000 1655 1663
20. H. Miyake, I. Hara, S. Kamidono Novel therapeutic strategy for advanced prostate cancer using antisense oligodeoxynucleotides targeting anti-apoptotic genes upregulated after androgen withdrawal to delay androgen-independent progression and enhance chemosensitivity Int J Urol 8 2001 337 349
21. H. Miyake, M. Gleave, S. Kamidono Overexpression of clusterin in transitional cell carcinoma of the bladder is related to disease progression and recurrence Urology 59 2002 150 154
22. S.T. Crooke Therapeutic applications of oligonucleotides Annu Rev Pharmacol Toxicol 32 1992 329 376
23. R.W. Wagner The state of the art in antisense research Nat Med 1 1995 1116 1118
24. B.P. Monia, J.F. Johnston, T. Geiger Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase Nat Med 2 1996 668 675
25. C. Cucco, B. Calabretta In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides Cancer Res 56 1996 4332 4337
26. A. Ziegler, G.H. Luedke, D. Fabbro Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence J Natl Cancer Inst 89 1997 1027 1036
27. H. Miyake, A. Tolcher, M.E. Gleave Antisense Bcl-2 oligodeoxynucleotides inhibit progression to androgen-independence after castration in the Shionogi tumor model Cancer Res 59 1999 4030 4034
28. C. Cao, Y. Mu, D.E. Hallahan XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer Oncogene 23 2004 7047 7052
29. L. Milas, K.A. Mason, H. Ariga CpG oligodeoxynucleotide enhances tumor response to radiation Cancer Res 64 2004 5074 5077
30. A. Sak, R. Wurm, B. Elo Increased radiation-induced apoptosis and altered cell cycle progression of human lung cancer cell lines by antisense oligodeoxynucleotides targeting p53 and p21(WAF1/CIP1) Cancer Gene Ther 10 2003 926 934
31. P.C. Gokhale, D. McRae, B.P. Monia Antisense raf oligodeoxyribonucleotide is a radiosensitizer in vivo Antisense Nucleic Acid Drug Dev 9 1999 191 201
32. L.V. July, E. Beraldi, A. So Nucleotide-based therapies targeting clusterin chemosensitize human lung adenocarcinoma cells both in vitro and in vivo Mol Cancer Ther 3 2004 223 232
33. Y. Hu, G. Cherton-Horvat, V. Dragowska Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo Clin Cancer Res 9 2003 2826 2836
34. R.A. Olie, A.P. Simoes-Wust, B. Baumann A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy Cancer Res 60 2000 2805 2809
35. E. Edwards, L. Geng, J. Tan Phosphatidylinositol 3-kinase/Akt signaling in the response of vascular endothelium to ionizing radiation Cancer Res 62 2002 4671 4677
36. T. Zellweger, K. Chi, H. Miyake Enhanced radiation sensitivity in prostate cancer by inhibition of the cell survival protein clusterin Clin Cancer Res 8 2002 3276 3284
37. C.R. Yang, S. Yeh, K. Leskov Isolation of Ku70-binding proteins (KUBs) Nucleic Acids Res 27 1999 2165 2174
38. K.S. Leskov, D.Y. Klokov, J. Li Synthesis and functional analyses of nuclear clusterin, a cell death protein J Biol Chem 278 2003 11590 11600
39. C. Koch-Brandt, C. Morgans Clusterin A role in cell survival in the face of apoptosis? Prog Mol Subcell Biol 16 1996 130 149
40. S. Poon, T.M. Treweek, M.R. Wilson Clusterin is an extracellular chaperone that specifically interacts with slowly aggregating proteins on their off-folding pathway FEBS Lett 513 2002 259 266
41. D.T. Humphreys, J.A. Carver, S.B. Easterbrook-Smith Clusterin has chaperone-like activity similar to that of small heat shock proteins J Biol Chem 274 1999 6875 6881
42. I.P. Trougakos, A. So, B. Jansen Silencing expression of the clusterin/apolipoprotein j gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress Cancer Res 64 2004 1834 1842
43. N. Kyprianou, E.D. King, D. Bradbury Bcl-2 over-expression delays radiation-induced apoptosis without affecting the clonogenic survival of human prostate cancer cells Int J Cancer 70 1997 341 348
44. B. Movsas, J.D. Chapman, E.M. Horwitz Hypoxic regions exist in human prostate carcinoma Urology 53 1999 11 18
45. M. Scaltriti, S. Bettuzzi, R.M. Sharrard Clusterin overexpression in both malignant and nonmalignant prostate epithelial cells induces cell cycle arrest and apoptosis Br J Cancer 91 2004 1842 1850
46. T. Zellweger, S. Kiyama, K. Chi Overexpression of the cytoprotective protein clusterin decreases radiosensitivity in the human LNCaP prostate tumour model BJU Int 92 2003 463 469
47. H. Miayake, A. Tolcher, M.E. Gleave Chemosensitization and delayed androgen-independent recurrence of prostate cancer with the use of antisense Bcl-2 oligodeoxynucleotides J Natl Cancer Inst 92 2000 34 41
48. T. Zellweger, H. Miyake, L.V. July Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene clusterin Neoplasia 3 2001 360 367
49. M. Kamiyama, Y. Ichikawa, T. Ishikawa VEGF receptor antisense therapy inhibits angiogenesis and peritoneal dissemination of human gastric cancer in nude mice Cancer Gene Ther 9 2002 197 201
50. Q. Hasan, S.T. Tan, B. Xu Effects of five commonly used glucocorticoids on haemangioma in vitro Clin Exp Pharmacol Physiol 30 2003 140 144